Recurrence after complete resection and selective use of adjuvant therapy for stage i through III Merkel cell carcinoma

Cancer

Volumn 118, Issue 13, 2012, Pages 3311-3320

  Fields, Ryan C ^a   Busam, Klaus J ^a   Chou, Joanne F ^a   Panageas, Katherine S ^a   Pulitzer, Melissa P ^a   Allen, Peter J ^a   Kraus, Dennis H ^a   Brady, Mary S ^a   Coit, Daniel G ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Chemotherapy; Merkel cell carcinoma; Outcomes; Radiation therapy; Recurrence; Surgery; Treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE;

ADULT; AGE; AGED; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA; LYMPH NODE; LYMPH NODE DISSECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; REVIEW;

AGED; CARCINOMA, MERKEL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECURRENCE; SKIN NEOPLASMS;

EID: 84862540432     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26626     Document Type: Review

References (42)

1. Agelli M, Clegg LX,. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003; 49: 832-841. (Pubitemid 37314870)
2. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE,. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010; 37: 20-27.
3. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG,. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005; 23: 2300-2309. (Pubitemid 46218722)
4. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010; 63: 751-761.
5. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW,. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol. 2001; 8: 204-208. (Pubitemid 32294799)
6. Fields RC, Busam KJ, Chou JF, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg. 2011; 254: 465-475.
7. Toker C,. Trabecular carcinoma of the skin. Arch Dermatol. 1972; 105: 107-110.
8. Hui AC, Stillie AL, Seel M, Ainslie J,. Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre. Int J Radiat Oncol Biol Phys. 2011; 80: 1430-1435.
9. Bajetta E, Celio L, Platania M, et al. Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol. 2009; 16: 2985-2993.
10. Stokes JB, Graw KS, Dengel LT, et al. Patients with Merkel cell carcinoma tumors â1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol. 2009; 27: 3772-3777.
11. Muller A, Keus R, Neumann N, Lammering G, Schnabel T,. Management of Merkel cell carcinoma: case series of 36 patients. Oncol Rep. 2003; 10: 577-585.
12. Smith DE, Bielamowicz S, Kagan AR, Anderson PJ, Peddada AV,. Cutaneous neuroendocrine (Merkel cell) carcinoma. A report of 35 cases. Am J Clin Oncol. 1995; 18: 199-203.
13. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK,. Merkel cell carcinoma. Prognosis and management. Arch Surg. 1991; 126: 1514-1519.
14. Reichgelt BA, Visser O,. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer. 2011; 47: 579-585.
15. Rao NG,. Review of the role of radiation therapy in the management of Merkel cell carcinoma. Curr Probl Cancer. 2010; 34: 108-117.
16. Kudchadkar R, Deconti R,. Systemic treatments for Merkel cell carcinoma. Curr Probl Cancer. 2010; 34: 97-107.
17. Gonzalez RJ, Padhya TA, Cherpelis BS, et al. The surgical management of primary and metastatic Merkel cell carcinoma. Curr Probl Cancer. 2010; 34: 77-96.
18. Nghiem P, Sober A, Lemos B,; American Joint Committee on Cancer/Merkel Cell Carcinoma Task Force. Merkel cell carcinoma. In:, Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010: 315-323.
19. Schwartz JL, Griffith KA, Lowe L, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol. 2011; 29: 1036-1041.
20. Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011; 18: 2529-2537.
21. Miller SJ, Alam M, Andersen J, et al. Merkel cell carcinoma. J Natl Compr Canc Netw. 2009; 7: 322-332.
22. Hill AD, Brady MS, Coit DG,. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg. 1999; 86: 518-521. (Pubitemid 29195050)
23. Andea AA, Coit DG, Amin B, Busam KJ,. Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008; 113: 2549-2558.
24. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE,. The analysis of failure times in the presence of competing risks. Biometrics. 1978; 34: 541-554. (Pubitemid 9067879)
25. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD,. A note on competing risks in survival data analysis. Br J Cancer. 2004; 91: 1229-1235. (Pubitemid 39424779)
26. Gray RJ,. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16: 1141-1154.
27. Bichakjian CK, Coit DG, Wong SL,. Radiation versus resection for Merkel cell carcinoma. Cancer. 2010; 116: 1620-1622.
28. Garneski KM, Nghiem P,. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol. 2007; 57: 166-169. (Pubitemid 46899275)
29. Mojica P, Smith D, Ellenhorn JD,. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007; 25: 1043-1047. (Pubitemid 46596754)
30. Veness M, Foote M, Gebski V, Poulsen M,. The role of radiotherapy alone in patients with Merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010; 78: 703-709.
31. Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF,. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol. 2008; 15: 2509-2518.
32. Lewis KG, Weinstock MA, Weaver AL, Otley CC,. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006; 142: 693-700.
33. Jabbour J, Cumming R, Scolyer RA, Hruby G, Thompson JF, Lee S,. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage diseaseâresults from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol. 2007; 14: 1943-1952. (Pubitemid 46870931)
34. Poulsen M, Round C, Keller J, Tripcony L, Veness M,. Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limbâa review of 60 cases. Int J Radiat Oncol Biol Phys. 2010; 76: 393-397.
35. Fang LC, Lemos B, Douglas J, Iyer J, Nghiem P,. Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma. Cancer. 2010; 116: 1783-1790.
36. Poulsen MG, Rischin D, Porter I, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006; 64: 114-119. (Pubitemid 41831217)
37. Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group StudyâTROG 96:07. J Clin Oncol. 2003; 21: 4371-4376. (Pubitemid 46621814)
38. Poulsen M, Rischin D, Walpole E, et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study. Int J Radiat Oncol Biol Phys. 2001; 51: 156-163. (Pubitemid 32758875)
39. Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol. 2000; 18: 2493-2499. (Pubitemid 30415837)
40. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008; 319: 1096-1100. (Pubitemid 351300792)
41. Touze A, Le Bidre E, Laude H, et al. High levels of antibodies against Merkel cell polyomavirus identify a subset of patients with Merkel cell carcinoma with better clinical outcome. J Clin Oncol. 2011; 29: 1612-1619.
42. Paulson KG, Iyer JG, Tegeder AR, et al. Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol. 2011; 29: 1539-1546.